Your browser doesn't support javascript.
loading
High-dose cutaneous exposure to mite allergen induces IgG-mediated protection against anaphylaxis.
Hirai, T; Yoshioka, Y; Takahashi, H; Handa, T; Izumi, N; Mori, T; Uemura, E; Nishijima, N; Sagami, K; Yamaguchi, M; Eto, S; Nagano, K; Kamada, H; Tsunoda, S; Ishii, K J; Higashisaka, K; Tsutsumi, Y.
Affiliation
  • Hirai T; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Yoshioka Y; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Takahashi H; Vaccine Creation Project, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Handa T; BIKEN Center for Innovative Vaccine Research and Development, The Research Foundation for Microbial Diseases of Osaka University, Osaka, Japan.
  • Izumi N; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Mori T; Vaccine Creation Project, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Uemura E; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Nishijima N; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Sagami K; Laboratory of Innovative Antibody Engineering and Design, Center for Drug Innovation and Screening, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
  • Yamaguchi M; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Eto S; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Nagano K; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Kamada H; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Tsunoda S; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Ishii KJ; Laboratory of Biopharmaceutical Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
  • Higashisaka K; Laboratory of Biopharmaceutical Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
  • Tsutsumi Y; The Center for Advanced Medical Engineering and Informatics, Osaka University, Osaka, Japan.
Clin Exp Allergy ; 46(7): 992-1003, 2016 07.
Article in En | MEDLINE | ID: mdl-26892276
ABSTRACT

BACKGROUND:

The relationship among natural allergen exposure, induction of blocking antibody and the occurrence of atopic allergy-particularly in the presence of IgE production-is debatable.

OBJECTIVE:

To clarify the relationship between the dose of cutaneous exposure to dust mite allergen and susceptibility to the IgE-mediated allergic response in relation to IgG production.

METHODS:

NC/Nga mice were epicutaneously exposed to various doses of Dermatophagoides pteronyssinus allergen to induce atopic dermatitis-like skin lesions. We then evaluated the skin lesions, induction of mite-specific immune responses, and susceptibility to anaphylaxis.

RESULTS:

Dose-dependent exacerbation of atopic dermatitis-like skin lesions and increases in mite-specific IgG and IgE production were observed. However, mice exposed to relatively low doses of mite allergen showed hypersusceptibility to mite allergen-specific anaphylaxis. We also showed that adoptive transfer of total IgG from Dp-sensitized mice rescued mice from the hypersusceptibility seen in those exposed to low doses of mite allergen. CONCLUSIONS AND CLINICAL RELEVANCE High-dose cutaneous exposure to dust mites induced effective blocking IgG production, even if accompanied by IgE production. Our data might support the concept that an increase in IgG titre, not a decrease in IgE titre, is a marker of clinical improvement in allergen-specific immunotherapy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Allergens / Antibodies, Blocking / Antigens, Dermatophagoides / Anaphylaxis Limits: Animals Language: En Journal: Clin Exp Allergy Journal subject: ALERGIA E IMUNOLOGIA Year: 2016 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Allergens / Antibodies, Blocking / Antigens, Dermatophagoides / Anaphylaxis Limits: Animals Language: En Journal: Clin Exp Allergy Journal subject: ALERGIA E IMUNOLOGIA Year: 2016 Document type: Article Affiliation country: Japan